Welcome to the ValueWiki Biogen Idec Inc (BIIB) article! Register for free or click the "edit" link to contribute!    

Biogen Idec Inc (BIIB)

From ValueWiki

Jump to: navigation, search
This summary section needs content! Click Here to begin writing.
Have a question about Biogen Idec Inc? Ask it on the Message Board or Chat Room
Visit the Apple, Inc. page for an example of a complete article.

Contents

Today 5d 3m 6m 1y 2y 5y Max



Funds w/ BIIB: 177
Rank: 181 / 351



Company Analysis

You can add your own information here - just click the blue edit tab. Or view examples at the Start a new article page.

The edit window has shortcut and help links if you need them.[1] Be bold!

News Feed

12/02/08 7:12 am FDA speeds up review of Cell Therapeutics drug (at bizjournals.com)
12/02/08 5:12 am [$$] A Bubble for Bonds? (at RealMoney by TheStreet.com)
12/01/08 5:12 pm Final Glance: Biotechnology companies (AP)
12/01/08 3:12 pm A Better Way to Invest in Biotech? (at Motley Fool)
12/01/08 1:12 pm Midday Glance: Biotechnology companies (AP)
12/01/08 11:12 am Get a Bear Market Do-Over (at Motley Fool)
12/01/08 10:12 am Early Glance: Biotechnology companies (AP)
12/01/08 7:12 am Cell Therapeutics gets FDA priority review on drug (AP)
11/30/08 9:11 am This Week's 'Barron's' Roundup (at TheStreet.com)
11/29/08 11:11 am Cell Therapeutics, Spectrum in deal to sell Zevalin (at bizjournals.com)
More News...

Risks

This section needs content! Click the blue edit link (to the right) to contribute.

Research Links

Biogen Idec Inc Snapshot
Biogen Idec Inc Leadership
Biogen Idec Inc Fundamentals
Biogen Idec Inc Technical Analysis
Biogen Idec Inc Message Boards

Options

Notes

  1. This is a sample reference.
Personal tools